Every open market buy and sale of RxSight, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $118K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RXST insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RXST officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RXST insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Eric WeinbergSee remarks | Sale | 2,041 | $6.96 | $14K | 200,348 | Sep 2Form 4 |
| Sep 2, 2026 | Ilya GoldshlegerCOO | Sale | 2,041 | $6.96 | $14K | 81,509 | Sep 2Form 4 |
| Sep 2, 2026 | Mark WilterdingCFO | Sale | 7,765 | $6.96 | $54K | 25,049 | Sep 2Form 4 |
| Sep 2, 2026 | Ronald M Kurtz MDChief Medical Officer | Sale | 5,100 | $6.96 | $35K | 71,775 | Sep 2Form 4 |
| Mar 12, 2025 | Tamara FountainDirector | Sale plan | 7,000 | $25.71 | $180K | 24,793 | Mar 13Form 4 |
| Jan 22, 2025 | Shweta ManiarDirector | Sale plan | 3,519 | $30.87 | $109K | 7,383 | Jan 27Form 4 |
| Jan 16, 2025 | Jesse Anderson CorleyDirector | Buy | 3,210 | $31.16 | $100K | 3,210 | Jan 17Form 4 |
| Nov 29, 2024 | Ilya GoldshlegerSee remarks | Sale plan | 3,105 | $46.08 | $143K | 42,246 | Dec 3Form 4 |
| Nov 26, 2024 | Ilya GoldshlegerSee remarks | Sale plan | 6,200 | $45.44 | $282K | 42,246 | Nov 26Form 4 |
| Nov 26, 2024 | Shweta ManiarDirector | Sale plan | 3,782 | $45.88 | $174K | 10,902 | Nov 26Form 4 |
| Nov 18, 2024 | Ilya GoldshlegerSee remarks | Sale plan | 7,975 | $45.61 | $364K | 42,246 | Nov 18Form 4 |
| Nov 13, 2024 | Jesse Anderson CorleyDirector | Buy | 22,476 | $45.14 | $1M | 38,438 | Nov 14Form 4 |
| Nov 12, 2024 | Ilya GoldshlegerSee remarks | Sale plan | 1,330 | $46.13 | $61K | 42,246 | Nov 14Form 4 |
| Nov 7, 2024 | Ilya GoldshlegerSee remarks | Sale plan | 3,100 | $55.00 | $170K | 42,246 | Nov 8Form 4 |
RXST insider trading FAQ
Are RXST insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of RXST on the open market in 0 trades, and 4 sold $118K in 4 trades.
When did an RXST insider last buy shares?
Jesse Anderson Corley (Director) bought 3,210 shares for $100K on Jan 16, 2025, reported on Jan 17, 2025.
When did an RXST insider last sell shares?
Eric Weinberg (See remarks) sold 2,041 shares for $14K on Sep 2, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
